Plus   Neg

Cannabis Company Tilray Inks Distribution Deal With Novartis, Shares Up 12%

Shares of Tilray Inc. (TLRY) are currently up 12% on Tuesday after the Canadian marijuana company announced that its Tilray Canada Ltd. unit has entered a global supply and distribution agreement with Swiss drugmaker Novartis AG's subsidiary Sandoz AG to sell and distribute medical cannabis products globally.

As a part of the deal, Tilray will be able to use Sandoz's global distribution channels to support sales of Tilray's non-smokable/non-combustible medical cannabis products.

The agreement also allows both companies to collaborate "to educate pharmacists and physicians about medical cannabis products," and to "develop new innovative medical cannabis products," the statement said.

"This agreement represents a major milestone in the movement to provide access to safe, GMP-certified medical cannabis to patients in need across the world," Tilray CEO Brendan Kennedy said.

"Tilray is a global company and we're thrilled to build upon the success and momentum from our existing agreement with Sandoz Canada by taking our partnership global. Sandoz AG will be a valuable partner as we work together to improve access to the highest quality medical cannabis products in countries all over the world."

TLRY is currently trading at $73.42, up $7.53 or 11.42%, on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup. The U.S. Department of Justice said it settled with a Florida-based IT recruiting and staffing company for immigration-related discrimination against non-U.S. citizens, including asylees. Perspective Talent LLC, a Pembroke Pines company, was found by the DOJ to have posted discriminatory job advertisements that unlawfully excluded individuals who are authorized to work in the U.S.
Follow RTT